Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Renalytix PLC

RENX.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Advanced Medical Equipment & Technology ·

UK Micro Cap Analyst: N/A

Last Close

$0.06

▲ +0.00%

Market Cap $24.16M · Vol 293.94K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$24.16M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

80.85

Momentum

Beta

1.98

vs Market

52W High

$0.21

73.68% below

52W Low

$0.02

160.27% above

Volume

293.94K

Avg 1.30M

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

73.14%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Renalytix PLC (RENX.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RENX.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+10.81%

+46.43%

+127.78%

-0.61%

YTD

-30.51%

-28.70%

-95.74%

-99.60%

Financials & Valuation

TTM · Annual

Total Revenue	$3.00M
Net Income	$-20,400,000.00
Revenue Growth (YoY)	+27.90%
Gross Margin	40.00%
Operating Margin	-566.67%
Net Profit Margin	-680.00%
ROE	N/A
ROA · ROIC	-330.40% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	9.11
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	437.02M

Technical Indicators

50-Day SMA	$0.04
200-Day SMA	$0.05
RSI (14)	80.85
Beta	1.98
52-Week High	$0.21
52-Week Low	$0.02

Volume Today	293.94K
Avg Daily Volume (30D)	1.30M
Relative Volume	0.23x
Volatility (10D)	119.31
Volatility (30D)	91.16
Free Float	73.14%

Analyst Consensus

N/A

Current Price $0.06

Mean Target N/A

52W Low$0.02 52W High$0.21

Current

Target

$0.02 $0.21

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG00VPNC5Z0

ISINGB00BYWL4Y04

CountryUnited Kingdom

Sub-IndustryMedical Diagnostic & Testing Equipment

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SRT.DE Sartorius AG -1.14% BIOT.ST Biotage AB +0.14% EUZ.DE Eckert & Ziegler SE -0.44% VREX Varex Imaging Corp -0.05% REG1V.HE Revenio Group Oyj +5.89%

Company Profile

Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.